ESMO in the Alps
The ESMO Congress 2026 will be the global stage for the exchange and debate of translational cancer science of excellence, first announcements of practice-changing data, and multidisciplinary must-have conversations set to spur transformative therapies against cancer.
ESMO in the Alps offers a unique opportunity to delve deeper into the presented findings. This event will include both a live meeting and a broadcasted webinar. The Scientific Committee will rigorously assess the outcomes and their implications for Swiss clinical practice. Engage with us as we explore the practice-changing content from ESMO. Participate in lively discussions and analyses of the latest data, connecting with experts from around the globe during the on-site session or easily join the conversation from the comfort of your home.
Steering Committee
Prof. (em.) Dr. med. Jörg Beyer, Inselspital Bern
Dr. med. Eugenio Fernandez, Les hôpitaux universitaires de Genève
Dr. med. Daniel Helbling, Onkozentrum Zürich
Prof. Dr. med. Dr. phil. Andreas Wicki, Universitätsspital Zürich
Credits
SGAIM, SGH, SGMO, SRO
Program
will follow shortly
Contact us
Swiss Cancer Institute
Effingerstrasse 33
CH-3008 Berne
Tel: +41 31 389 91 91
events@swisscancerinstitute.ch
Sponsors
Platinum Sponsor
-
AstraZeneca AG
Gold Sponsor
-
Astellas Pharma AG
-
JJ Johnson Johnson Innovative Medicine - Janssen Cilag AG
-
Takeda Pharma AG
Silver Sponsor
-
Amgen Switzerland AG
-
Bayer (Schweiz) AG
-
Daiichi Sankyo (Schweiz) AG
-
Eli Lilly (Suisse) SA
-
GSK GlaxoSmithKline AG
-
Ipsen Pharma GmbH
-
Merck (Schweiz) AG
-
Novartis Pharma Schweiz AG
-
Pfizer Schweiz
-
Roche Pharma (Schweiz) AG
Bronze Sponsor
-
MSD Merck Sharp Dohme AG